Skip to main content

InfuSystem Holdings, Inc

INFU
Exchange
NYSE
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001337013

No open-market purchases or sales by InfuSystem Holdings, Inc insiders were filed in the last 90 days; 100 institutions reported holding it in 13F filings for Q2 2026, worth $146.0M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding InfuSystem Holdings, Inc changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of INFU: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders94940
Shares14.0M13.0M−986.9K (−7.1%)
Value$75.4M$81.1M+$5.77M (+7.7%)

New holders (25)

Institutions that held InfuSystem Holdings, Inc at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to INFU in Q2 2025
InstitutionSharesValue% of portfolio
Essex Investment Management Co LLC275,763$1.72M0.31%
Truffle Hound Capital, LLC180,000$1.12M0.74%
Arrowstreet Capital, Limited Partnership140,374$875.9K0.00%
AQR Capital Management LLC59,580$371.8K0.00%
Y-Intercept (Hong Kong) Ltd47,111$294.0K0.01%
Integrated Quantitative Investments LLC38,954$243.1K0.07%
Qube Research & Technologies Ltd37,499$234.0K0.00%
Brevan Howard Capital Management LP36,483$227.7K0.00%
Squarepoint Ops LLC30,156$188.2K0.00%
XTX Topco Ltd29,688$185.3K0.01%
Aster Capital Management (DIFC) Ltd24,971$155.8K0.04%
Ground Swell Capital, LLC21,693$135.4K0.22%
Jain Global LLC21,400$133.5K0.00%
Point72 Asia (Singapore) Pte. Ltd.14,386$89.8K0.02%
HRT Financial LP13,808$86.0K0.00%
Williams & Novak, LLC12,280$76.6K0.07%
Raymond James Financial Inc5,269$32.9K0.00%
Point72 (DIFC) Ltd1,300$8.11K0.00%
Skopos Labs, Inc.302$1.89K0.00%
Advisor Group Holdings, Inc.285$1.78K0.00%
Smartleaf Asset Management LLC222$1.36K0.00%
Essential Partners LLC213$1.33K0.00%
Nisa Investment Advisors, LLC141$8800.00%
EverSource Wealth Advisors, LLC117$7300.00%
Allworth Financial LP30$1880.00%

Sold out (25)

Institutions that held InfuSystem Holdings, Inc at the end of Q1 2025 and filed for Q2 2025 without it.